164 related articles for article (PubMed ID: 27038647)
1. Towards personalized diagnostics via longitudinal study of the human plasma N-glycome.
Hennig R; Cajic S; Borowiak M; Hoffmann M; Kottler R; Reichl U; Rapp E
Biochim Biophys Acta; 2016 Aug; 1860(8):1728-38. PubMed ID: 27038647
[TBL] [Abstract][Full Text] [Related]
2. Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery.
Gizaw ST; Ohashi T; Tanaka M; Hinou H; Nishimura S
Biochim Biophys Acta; 2016 Aug; 1860(8):1716-27. PubMed ID: 26968461
[TBL] [Abstract][Full Text] [Related]
3. Methods for the absolute quantification of N-glycan biomarkers.
Etxebarria J; Reichardt NC
Biochim Biophys Acta; 2016 Aug; 1860(8):1676-87. PubMed ID: 26953846
[TBL] [Abstract][Full Text] [Related]
4. Stability of N-glycan profiles in human plasma.
Gornik O; Wagner J; Pucić M; Knezević A; Redzic I; Lauc G
Glycobiology; 2009 Dec; 19(12):1547-53. PubMed ID: 19726492
[TBL] [Abstract][Full Text] [Related]
5. Glycomics and glycoproteomics focused on aging and age-related diseases--Glycans as a potential biomarker for physiological alterations.
Miura Y; Endo T
Biochim Biophys Acta; 2016 Aug; 1860(8):1608-14. PubMed ID: 26801879
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of disease: The human N-glycome.
Lauc G; Pezer M; Rudan I; Campbell H
Biochim Biophys Acta; 2016 Aug; 1860(8):1574-82. PubMed ID: 26500099
[TBL] [Abstract][Full Text] [Related]
7. Plasma N-Glycome Signature of Down Syndrome.
Borelli V; Vanhooren V; Lonardi E; Reiding KR; Capri M; Libert C; Garagnani P; Salvioli S; Franceschi C; Wuhrer M
J Proteome Res; 2015 Oct; 14(10):4232-45. PubMed ID: 26334954
[TBL] [Abstract][Full Text] [Related]
8. Plasma N-glycome composition associates with chronic low back pain.
Trbojević-Akmačić I; Vučković F; Vilaj M; Skelin A; Karssen LC; Krištić J; Jurić J; Momčilović A; Šimunović J; Mangino M; De Gregori M; Marchesini M; Dagostino C; Štambuk J; Novokmet M; Rauck R; Aulchenko YS; Primorac D; Kapural L; Buyse K; Mesotten D; Williams FMK; van Zundert J; Allegri M; Lauc G
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2124-2133. PubMed ID: 29981899
[TBL] [Abstract][Full Text] [Related]
9. The promise of protein glycosylation for personalised medicine.
Almeida A; Kolarich D
Biochim Biophys Acta; 2016 Aug; 1860(8):1583-95. PubMed ID: 26987810
[TBL] [Abstract][Full Text] [Related]
10. High-throughput glycomics: optimization of sample preparation.
Akmačić IT; Ugrina I; Štambuk J; Gudelj I; Vučković F; Lauc G; Pučić-Baković M
Biochemistry (Mosc); 2015 Jul; 80(7):934-42. PubMed ID: 26542006
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G N-Glycans as Potential Postgenomic Biomarkers for Hypertension in the Kazakh Population.
Gao Q; Dolikun M; Štambuk J; Wang H; Zhao F; Yiliham N; Wang Y; Trbojević-Akmačić I; Zhang J; Fang H; Sun Y; Peng H; Zhao Z; Liu D; Liu J; Li Q; Sun Q; Wu L; Lauc G; Wang W; Song M
OMICS; 2017 Jul; 21(7):380-389. PubMed ID: 28692416
[TBL] [Abstract][Full Text] [Related]
12. UniCarbKB: New database features for integrating glycan structure abundance, compositional glycoproteomics data, and disease associations.
Campbell MP; Packer NH
Biochim Biophys Acta; 2016 Aug; 1860(8):1669-75. PubMed ID: 26940363
[TBL] [Abstract][Full Text] [Related]
13. Platform technology to identify potential disease markers and establish heritability and environmental determinants of the human serum N-glycome.
Tharmalingam T; Mariño K; Rudd PM
Carbohydr Res; 2010 Jul; 345(10):1280-2. PubMed ID: 20447618
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome.
Zoldoš V; Horvat T; Novokmet M; Cuenin C; Mužinić A; Pučić M; Huffman JE; Gornik O; Polašek O; Campbell H; Hayward C; Wright AF; Rudan I; Owen K; McCarthy MI; Herceg Z; Lauc G
Epigenetics; 2012 Feb; 7(2):164-72. PubMed ID: 22395466
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation.
Arnold JN; Saldova R; Hamid UM; Rudd PM
Proteomics; 2008 Aug; 8(16):3284-93. PubMed ID: 18646009
[TBL] [Abstract][Full Text] [Related]
16. Amplification and Preparation of Cellular O-Glycomes for Functional Glycomics.
Li Z; Zhang Q; Ashline D; Zhu Y; Lasanajak Y; Chernova T; Reinhold V; Cummings RD; Wang PG; Ju T; Smith DF; Song X
Anal Chem; 2020 Aug; 92(15):10390-10401. PubMed ID: 32539345
[TBL] [Abstract][Full Text] [Related]
17. Total plasma N-glycome changes during pregnancy.
Ruhaak LR; Uh HW; Deelder AM; Dolhain RE; Wuhrer M
J Proteome Res; 2014 Mar; 13(3):1657-68. PubMed ID: 24527664
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing Benign and Malignant Thyroid Nodules and Identifying Lymph Node Metastasis in Papillary Thyroid Cancer by Plasma
Zhang Z; Reiding KR; Wu J; Li Z; Xu X
Front Endocrinol (Lausanne); 2021; 12():692910. PubMed ID: 34248851
[TBL] [Abstract][Full Text] [Related]
19. Optimized workflow for preparation of APTS-labeled N-glycans allowing high-throughput analysis of human plasma glycomes using 48-channel multiplexed CGE-LIF.
Ruhaak LR; Hennig R; Huhn C; Borowiak M; Dolhain RJ; Deelder AM; Rapp E; Wuhrer M
J Proteome Res; 2010 Dec; 9(12):6655-64. PubMed ID: 20886907
[TBL] [Abstract][Full Text] [Related]
20. The analysis of the human plasma N-glycome in endometriosis patients.
Berkes E; Mužinić A; Rigo J; Tinneberg HR; Oehmke F
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):107-15. PubMed ID: 24051301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
